Blue Jet Healthcare Ltd

Blue Jet Health Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Blue Jet Healthcare Ltd

₹ 717 4.99%
12 Sep - close price
bluejethealthcare.com BSE: 544009 NSE: BLUEJET
About

Incorporated in 1968, Blue Jet Healthcare (earlier called Jet Chemicals Pvt Ltd) is a pharmaceutical and healthcare ingredient & intermediate company and the first manufacturer of saccharin and its salts (artificial sweeteners) in India.[1]

Key Points

Product Portfolio
A) Contrast Media Intermediates (67.7% of FY24 revenue)[1]
Contrast media are chemical agents that enhance imaging clarity for diagnostic purposes, making tissues more visible under X-rays, CT scans, MRIs, and ultrasounds. The company supplies critical starting and advanced intermediates to the world's top contrast media manufacturers.

Website BSE NSE
  • Market Cap ₹ 12,437 Cr.
  • Current Price ₹ 717
  • High / Low ₹ 1,028 / 464
  • Stock P/E 34.7
  • Book Value ₹ 65.3
  • Dividend Yield 0.17 %
  • ROCE 39.8 %
  • ROE 30.2 %
  • Face Value ₹ 2.00
Edit ratios

Pros

  • Company is almost debt free.
  • Company is expected to give good quarter
  • Company has a good return on equity (ROE) track record: 3 Years ROE 26.8%

Cons

  • Stock is trading at 11.0 times its book value

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Healthcare Healthcare Pharmaceuticals & Biotechnology Pharmaceuticals

Part of BSE Healthcare BSE SmallCap BSE Allcap Nifty Microcap 250 Nifty Total Market

Edit Columns
Loading peers table ...

Quarterly Results

Standalone Figures in Rs. Crores / View Consolidated

Jun 2022 Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025
145 190 169 217 180 181 167 184 163 208 318 340 355
106 132 117 147 121 119 112 131 119 139 194 200 234
Operating Profit 38 59 52 70 59 63 55 53 44 69 124 140 121
OPM % 27% 31% 31% 32% 33% 35% 33% 29% 27% 33% 39% 41% 34%
4 7 6 6 5 8 -3 9 9 12 13 12 8
Interest 0 0 0 0 0 0 0 0 0 0 0 0 1
Depreciation 6 6 7 6 6 6 8 8 3 5 5 5 6
Profit before tax 36 59 51 70 58 64 44 54 49 77 132 147 123
Tax % 24% 26% 27% 27% 24% 26% 27% 27% 24% 24% 25% 25% 26%
28 44 38 51 44 48 32 40 38 58 99 110 91
EPS in Rs 1.61 2.53 2.16 2.92 2.54 2.76 1.85 2.29 2.18 3.36 5.71 6.35 5.26
Raw PDF

Profit & Loss

Standalone Figures in Rs. Crores / View Consolidated

Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 TTM
538 499 683 721 712 1,030 1,222
325 292 434 502 481 652 767
Operating Profit 214 207 249 219 231 378 454
OPM % 40% 41% 36% 30% 32% 37% 37%
6 9 19 24 18 46 46
Interest 7 5 3 1 0 0 1
Depreciation 18 20 22 25 28 18 20
Profit before tax 194 190 243 217 220 406 479
Tax % 25% 26% 25% 26% 26% 25%
145 142 182 160 164 305 359
EPS in Rs 24,118.33 1,428.57 10.47 9.23 9.44 17.59 20.68
Dividend Payout % 0% 0% 0% 0% 11% 7%
Compounded Sales Growth
10 Years: %
5 Years: 14%
3 Years: 15%
TTM: 76%
Compounded Profit Growth
10 Years: %
5 Years: 16%
3 Years: 18%
TTM: 118%
Stock Price CAGR
10 Years: %
5 Years: %
3 Years: %
1 Year: 43%
Return on Equity
10 Years: %
5 Years: 31%
3 Years: 27%
Last Year: 30%

Balance Sheet

Standalone Figures in Rs. Crores / View Consolidated

Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Equity Capital 0.60 10 35 35 35 35
Reserves 198 330 487 647 811 1,098
74 53 19 5 3 21
92 143 173 176 211 263
Total Liabilities 364 536 713 862 1,059 1,418
107 0 156 151 172 300
CWIP 2 3 3 30 147 89
Investments 26 37 94 189 250 187
229 497 460 491 489 841
Total Assets 364 536 713 862 1,059 1,418

Cash Flows

Standalone Figures in Rs. Crores / View Consolidated

Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
122 137 146 142 241 46
-45 -61 -76 -147 -264 -35
-72 -21 -56 -4 -2 -19
Net Cash Flow 5 55 14 -10 -24 -8

Ratios

Standalone Figures in Rs. Crores / View Consolidated

Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Debtor Days 80 105 121 121 91 124
Inventory Days 120 201 133 137 151 209
Days Payable 90 101 72 58 35 70
Cash Conversion Cycle 110 204 183 199 206 262
Working Capital Days 55 105 103 120 92 157
ROCE % 58% 53% 35% 30% 40%

Shareholding Pattern

Numbers in percentages

Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025
86.00% 86.00% 86.00% 86.00% 86.00% 86.00% 86.00%
2.93% 2.01% 2.02% 2.18% 1.10% 2.28% 1.97%
3.70% 3.04% 2.14% 1.75% 2.02% 1.33% 0.95%
7.37% 8.97% 9.83% 10.06% 10.87% 10.38% 11.08%
No. of Shareholders 55,58948,62542,88241,93343,00354,58170,772

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

Annual reports

DRHP

Concalls